23andMe to offer genetic reports on diabetes Dutch pharmacists dodge Novartis cancer drug market exclusivity New class of drugs offer alternative to statins Sandoz CEO Richard Francis to step down httpbit.ly2O6DJ2e pharmapic.twitter.

- 23andMe to offer genetic reports on #diabetes - Dutch pharmacists dodge #Novartis #cancer drug market exclusivity - New class of drugs offer alternative to #statins - Sandoz #CEO Richard Francis to step down http://bit.ly/2O6DJ2e  #pharmapic.twitter.

- 23andMe to offer genetic reports on #diabetes - Dutch pharmacists dodge #Novartis #cancer drug market exclusivity - New class of drugs offer alternative to #statins - Sandoz #CEO Richard Francis to step down http://bit.ly/2O6DJ2e  #pharma pic.twitter.com/7HH9kdIg7V

More From BioPortfolio on "- 23andMe to offer genetic reports on #diabetes - Dutch pharmacists dodge #Novartis #cancer drug market exclusivity - New class of drugs offer alternative to #statins - Sandoz #CEO Richard Francis to step down http://bit.ly/2O6DJ2e  #pharmapic.twitter."